M Mora-Worms

472 total citations
8 papers, 411 citations indexed

About

M Mora-Worms is a scholar working on Molecular Biology, Occupational Therapy and Rehabilitation. According to data from OpenAlex, M Mora-Worms has authored 8 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Occupational Therapy and 2 papers in Rehabilitation. Recurrent topics in M Mora-Worms's work include Wound Healing and Treatments (2 papers), TGF-β signaling in diseases (2 papers) and Occupational Health and Performance (2 papers). M Mora-Worms is often cited by papers focused on Wound Healing and Treatments (2 papers), TGF-β signaling in diseases (2 papers) and Occupational Health and Performance (2 papers). M Mora-Worms collaborates with scholars based in United States, Switzerland and France. M Mora-Worms's co-authors include Cathy H. Lucas, Laura Bald, B M Fendly, Michael A. Palladino, I S Figari, Eric J. Patzer, David T.W. Fei, Catherine Lucas, Peter M. Henson and David W. H. Riches and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and Pharmaceutical Research.

In The Last Decade

M Mora-Worms

8 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Mora-Worms United States 6 127 123 108 59 42 8 411
Irene Boll Germany 13 168 1.3× 108 0.9× 78 0.7× 56 0.9× 7 0.2× 66 535
Esther Fasse Netherlands 13 45 0.4× 29 0.2× 335 3.1× 59 1.0× 9 0.2× 16 446
A. Hoek Netherlands 8 83 0.7× 134 1.1× 191 1.8× 47 0.8× 36 0.9× 11 539
R J Hartle United States 8 200 1.6× 68 0.6× 64 0.6× 14 0.2× 77 1.8× 10 440
DY Tzeng United States 7 98 0.8× 8 0.1× 128 1.2× 34 0.6× 43 1.0× 10 343
Sandhya Das United States 8 154 1.2× 15 0.1× 120 1.1× 121 2.1× 33 0.8× 14 368
Fabrice Licata France 7 106 0.8× 7 0.1× 251 2.3× 111 1.9× 12 0.3× 8 402
Feldman Jd United States 7 98 0.8× 36 0.3× 67 0.6× 28 0.5× 34 0.8× 19 322
Hernan Martinez United States 9 88 0.7× 27 0.2× 160 1.5× 88 1.5× 36 0.9× 15 355
GC Jr Bagby United States 10 136 1.1× 25 0.2× 255 2.4× 92 1.6× 48 1.1× 20 592

Countries citing papers authored by M Mora-Worms

Since Specialization
Citations

This map shows the geographic impact of M Mora-Worms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Mora-Worms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Mora-Worms more than expected).

Fields of papers citing papers by M Mora-Worms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Mora-Worms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Mora-Worms. The network helps show where M Mora-Worms may publish in the future.

Co-authorship network of co-authors of M Mora-Worms

This figure shows the co-authorship network connecting the top 25 collaborators of M Mora-Worms. A scholar is included among the top collaborators of M Mora-Worms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Mora-Worms. M Mora-Worms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hongo, Jo-Anne, M Mora-Worms, Catherine Lucas, & B M Fendly. (1995). Development and Characterization of Murine Monoclonal Antibodies to the Latency-Associated Peptide of Transforming Growth Factor β 1. Hybridoma. 14(3). 253–260. 18 indexed citations
2.
Zioncheck, Thomas F., Louise Richardson, M Mora-Worms, et al.. (1994). Pharmacokinetics and Tissue Distribution of Recombinant Human Transforming Growth Factor Beta1 After Topical and Intravenous Administration in Male Rats. Pharmaceutical Research. 11(2). 213–220. 52 indexed citations
3.
Noble, Paul W., Peter M. Henson, Cathy H. Lucas, et al.. (1993). Transforming growth factor- beta primes macrophages to express inflammatory gene products in response to particulate stimuli by an autocrine/paracrine mechanism.. The Journal of Immunology. 151(2). 979–989. 51 indexed citations
4.
Mora-Worms, M, et al.. (1993). An evaluation of mechanisms by which tolerance to organ-specific antigens is lost using a transgenic mouse model. The Journal of Immunology. 150(4). 1234–1243. 3 indexed citations
5.
Lucas, Cathy H., et al.. (1991). The measurement of staphylococcal protein A by ELISA in immunoglobulin preparations. Biologicals. 19(4). 271–279. 2 indexed citations
6.
Fei, David T.W., et al.. (1990). Cyclic AMP response to recombinant human relaxin by cultured human endometrial cells—A specific and high throughput in vitro bioassay. Biochemical and Biophysical Research Communications. 170(1). 214–222. 79 indexed citations
7.
Lucas, Cathy H., Laura Bald, B M Fendly, et al.. (1990). The autocrine production of transforming growth factor-beta1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA.. The Journal of Immunology. 145(5). 1415–1422. 152 indexed citations
8.
Lucas, Cathy H., Laura Bald, R Jaffe, et al.. (1989). An enzyme-linked immunosorbent assay to study human relaxin in human pregnancy and in pregnant rhesus monkeys. Journal of Endocrinology. 120(3). 449–457. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026